National Institute of Allergy and Infectious Diseases (NIAID) Researchers Provide Details of New Studies and Findings in the Area of Ebola Virus (Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase ...)

Press/Media

Period17 Apr 2024

Media coverage

1

Media coverage

  • TitleNational Institute of Allergy and Infectious Diseases (NIAID) Researchers Provide Details of New Studies and Findings in the Area of Ebola Virus (Heterologous cAd3-Ebola and MVA-EbolaZ vaccines are safe and immunogenic in US and Uganda phase ...)
    Media name/outletVaccine Daily
    Country/TerritoryUnited States
    Date17/04/24
    PersonsMerlin Robb